| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -0.63% | -317.24% | 87.77% | 60/68 | 2.31% | 羚锐制药 | 6.99% | 行业排名> |
| 2025-12-31 | -5.15% | 1.72% | -1387.5% | 55/68 | 2.77% | 羚锐制药 | 22.39% | 行业排名> |
| 2025-09-30 | 0.4% | 135.29% | 0% | 54/68 | 4.88% | 达仁堂 | 25.38% | 行业排名> |
| 2025-06-30 | 0.4% | 207.69% | 37.93% | 53/68 | 3.21% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 0.29% | -65.06% | 105.53% | 55/68 | 2.25% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | -5.24% | -1641.18% | -3182.35% | 56/68 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 0.17% | -90.71% | 30.77% | 58/68 | 5.46% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 0.13% | -86.73% | -84.34% | 57/68 | 2.54% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 0.83% | 419.23% | 144.12% | 52/68 | 1.97% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 0.34% | 325% | -81.42% | 55/68 | 2.03% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 1.83% | -16.06% | 86.73% | 57/68 | 7.62% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 0.98% | -15.52% | 476.92% | 58/68 | 5.2% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | -0.26% | -120.16% | -425% | 64/68 | 3.31% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 0.08% | -93.04% | -96.33% | 56/68 | 6.79% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 2.18% | -70.26% | 87.93% | 55/68 | 5.19% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 1.16% | -63.86% | -10.08% | 57/68 | 3.33% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 1.29% | -50.38% | 12.17% | 48/68 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 1.15% | -82.94% | -84.31% | 59/68 | 4.51% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 7.33% | 13.12% | 128.35% | 33/68 | 7.47% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 3.21% | -22.84% | 23.46% | 46/68 | 4.6% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 2.6% | 7.44% | -61.42% | 32/68 | 2.63% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 6.74% | -32.06% | 4.01% | 36/68 | 0.07% | 长药退 | 7.37% | 行业排名> |
| 2020-09-30 | 6.48% | -30.1% | 55.77% | 35/68 | 6.89% | 以岭药业 | 7.15% | 行业排名> |
| 2020-06-30 | 4.16% | -12.24% | 71.9% | 31/68 | 3.83% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | 2.42% | -15.38% | -75.6% | 24/68 | 2.18% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | 9.92% | 11.21% | 7.01% | 28/68 | 6.88% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 9.27% | 11.69% | 95.57% | 18/68 | 7.39% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 4.74% | 4.18% | 65.73% | 34/68 | 4.75% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 2.86% | 47.42% | -67.94% | 30/68 | 2.94% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | 8.92% | -19.35% | 7.47% | 37/68 | 7.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 8.3% | -13.36% | 82.42% | 27/68 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 4.55% | -35.55% | 134.54% | 37/68 | 5.05% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 1.94% | -31.21% | -82.46% | 41/68 | 2.78% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 11.06% | 12.4% | 15.45% | 29/68 | 9.95% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 9.58% | 13.11% | 35.69% | 23/68 | 8.4% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 7.06% | 32.21% | 150.35% | 21/68 | 5.23% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 2.82% | 4.83% | -71.34% | 28/68 | 2.66% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | 9.84% | 171.07% | 16.17% | 33/68 | 10.19% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 8.47% | -19.49% | 58.61% | 30/68 | 9.47% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 5.34% | 7.01% | 98.51% | 31/68 | 5.15% | 济川药业 | 7.64% | 行业排名> |
| 2016-03-31 | 2.69% | -26.5% | -25.9% | 30/68 | 4.17% | 维康药业 | 38.23% | 行业排名> |

微信公众号
证券之星APP


